Alterations in Chemokine Receptor CCR5 Expression on Blood Dendritic Cells Correlate With Acute Graft-Versus-Host Disease
- 27 October 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 96 (8) , 753-762
Abstract
Background Dendritic cells (DC) are important in the development of acute graft-versus-host disease (GVHD) after allogeneic hemopoietic cell transplantation (alloHCT). The trafficking of immature DC from blood to GVHD target organs is likely to be regulated by chemokine receptors. Methods We performed flow cytometry to document the expression of chemokine receptors on circulating DC and correlated the findings after alloHCT with occurrence of acute GVHD. Results In normal individuals, plasmacytoid DC (pDC) expressed high levels of CCR5, whereas the major CD16+ myeloid DC subpopulation lacked CCR5. However, its expression on CD16+ cells was induced by culture in allogeneic mixed lymphocyte reaction supernatant, an effect largely mediated by interferon-γ. CCR5 was expressed on a significant proportion of CD16+ DC in 42 alloHCT patients, whereas it was down-regulated on pDC. The maximum percentage of CCR5+CD16+ DC, at any time after transplantation, correlated with acute GVHD, whereas the minimum CCR5+ on pDC showed a similar correlation. Before developing signs of GVHD, the maximum percentage CCR5+CD16+ DC was higher in patients with GVHD grades II to IV than in GVHD grades 0 and I, whereas the minimum percentage CCR5 on pDC was lower in GVHD grades II to IV than in GVHD grades 0 and I. CCR5 levels more than 20.5% on CD16+ myeloid DC and less than 22.6% on CD123+ pDC correlated with subsequent GVHD grades II to IV with high sensitivities and specificities. Conclusions These observations may reflect DC activation and altered homing during the alloimmune response and could allow early diagnosis and therapeutic intervention before the clinical diagnosis of GVHD.Keywords
This publication has 37 references indexed in Scilit:
- Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host DiseaseNew England Journal of Medicine, 2012
- Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activityBlood, 2012
- Chemokine Receptor CCR5 Mediates AlloImmune Responses in Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2010
- CCR5 Expression on Cells from HLA-Matched Unrelated Marrow Donors and Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2010
- Dendritic cell trafficking: More than just chemokinesCytokine & Growth Factor Reviews, 2005
- HIV and the CCR5-Δ32 resistance alleleFEMS Microbiology Letters, 2004
- Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studiesJournal of Molecular Modeling, 2003
- Persistence of host dendritic cells after transplantation is associated with graft-versus-host diseaseTransplantation and Cellular Therapy, 2003
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999